The Anti-Cancer Properties of the HIV Protease Inhibitor Nelfinavir

SIMPLE SUMMARY: To this day, cancer remains a medical challenge despite the development of cutting-edge diagnostic methods and therapeutics. Thus, there is a continual demand for improved therapeutic options for managing cancer patients. However, novel drug development requires decade-long time comm...

Descripción completa

Detalles Bibliográficos
Autores principales: Subeha, Mahbuba R., Telleria, Carlos M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699465/
https://www.ncbi.nlm.nih.gov/pubmed/33228205
http://dx.doi.org/10.3390/cancers12113437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699465/
https://www.ncbi.nlm.nih.gov/pubmed/33228205
http://dx.doi.org/10.3390/cancers12113437

Ejemplares similares